---
title: "Rinvoq (upadacitinib) in rheumatoid arthritis: Drug interactions questions"
description: "Drug interactions questions on Rinvoq (upadacitinib) in rheumatoid arthritis, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Questions: Does RINVOQ interact with food or grapefruit? What drug interactions does RINVOQ have in rheumatoid arthritis? 2 questions quoted from 2 sources."
canonical: "https://www.evicenter.com/medical-information/rinvoq--rheumatoid-arthritis/drug-interactions"
published: "2026-11-12T22:05:36-05:00"
modified: "2026-11-14T01:54:55-05:00"
---

# Rinvoq (upadacitinib) in rheumatoid arthritis: Drug interactions questions

Manufacturer: AbbVie Inc.  
Prescribing information: [Rinvoq](https://www.rinvoqhcp.com/prescribinginfo)

## Drug interactions

<a id="rinvoq-food-grapefruit"></a>

### Does RINVOQ interact with food or grapefruit?

> “Take one pill 1 time a day with or without food
> Advise patients to avoid food or drink containing grapefruit during treatment with RINVOQ”

Source: [RINVOQ: RINVOQ® (upadacitinib) Dosing for RA, PsA, AS, nr-axSpA, and GCA, captured 2026-11-08](https://www.rinvoqhcp.com/rheumatology/dosing-lab-monitoring#:~:text=Take%20one%20pill%201%20time,grapefruit%20during%20treatment%20with%20RINVOQ)

> “Coadministration of RINVOQ tablets with a high-fat/high-calorie meal had no clinically relevant 
> effect on upadacitinib exposures (increased AUCinf by 29% and Cmax by 39% to 60%).”

Source: [RINVOQ: Prescribing information, page 39, captured 2026-11-08](https://www.rinvoqhcp.com/prescribinginfo#page=39)

<a id="rinvoq-drug-interactions"></a>

### What drug interactions does RINVOQ have in rheumatoid arthritis?

> “Upadacitinib exposure is increased when it is co-administered with a strong CYP3A4 inhibitor 
> (such as ketoconazole, clarithromycin, and grapefruit), which may increase the risk of adverse 
> reactions [see Clinical Pharmacology (12.3)]. Monitor patients with rheumatoid arthritis, 
> psoriatic arthritis, ankylosing spondylitis, non-radiographic axial spondylarthritis, pJIA, or giant 
> cell arteritis closely for adverse reactions when co-administering RINVOQ/RINVOQ LQ with 
> strong CYP3A4 inhibitors. Food or drink containing grapefruit should be avoided during 
> treatment with RINVOQ/RINVOQ LQ.”

Source: [RINVOQ: Prescribing information, page 31, captured 2026-11-08](https://www.rinvoqhcp.com/prescribinginfo#page=31)

> “Upadacitinib exposure is decreased when it is co-administered with strong CYP3A4 inducers 
> (such as rifampin), which may lead to reduced therapeutic effect [see Clinical Pharmacology 
> (12.3)]. Coadministration of RINVOQ/RINVOQ LQ with strong CYP3A4 inducers is not 
> recommended.”

Source: [RINVOQ: Prescribing information, page 31, captured 2026-11-08](https://www.rinvoqhcp.com/prescribinginfo#page=31)

> “Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Non-radiographic Axial 
> Spondyloarthritis, pJIA, and Giant Cell Arteritis 
> No dosage adjustment is needed in patients receiving strong CYP3A4 inhibitors [see Drug 
> Interactions (7.1)].”

Source: [RINVOQ: Prescribing information, page 11, captured 2026-11-08](https://www.rinvoqhcp.com/prescribinginfo#page=11)

## Related pages
- [Medical information: Rinvoq (upadacitinib): Rheumatoid arthritis](https://www.evicenter.com/medical-information/rinvoq--rheumatoid-arthritis)
- [Indication](https://www.evicenter.com/medical-information/rinvoq--rheumatoid-arthritis/indication)
- [Pharmacology](https://www.evicenter.com/medical-information/rinvoq--rheumatoid-arthritis/pharmacology)
- [Clinical trials](https://www.evicenter.com/medical-information/rinvoq--rheumatoid-arthritis/clinical-trials)
- [Safety](https://www.evicenter.com/medical-information/rinvoq--rheumatoid-arthritis/safety)
- [Specific populations](https://www.evicenter.com/medical-information/rinvoq--rheumatoid-arthritis/specific-populations)
- [Dosing and administration](https://www.evicenter.com/medical-information/rinvoq--rheumatoid-arthritis/dosing-and-administration)
- [Storage and supply](https://www.evicenter.com/medical-information/rinvoq--rheumatoid-arthritis/storage-and-supply)
- [Access and coverage](https://www.evicenter.com/medical-information/rinvoq--rheumatoid-arthritis/access-and-coverage)
